- Biochemotherapy for the treatment of metastatic malignant melanoma🔍
- Biochemotherapy in the treatment of metastatic melanoma ...🔍
- Biochemotherapy in the treatment of metastatic melanoma in ...🔍
- Biochemotherapy of metastatic melanoma in patients with or without ...🔍
- Biochemotherapy of metastatic malignant melanoma. Predictive ...🔍
- Chemotherapy Compared With Biochemotherapy for the Treatment ...🔍
- Treatment of metastatic melanoma with combined chemotherapy ...🔍
- Metastatic Melanoma🔍
Biochemotherapy in the treatment of metastatic melanoma in ...
Biochemotherapy for the treatment of metastatic malignant melanoma
“Biochemotherapy” is defined as a therapeutic regimen that includes, at a minimum, chemotherapy (either single-agent or combination) and interleukin-2.
Biochemotherapy in the treatment of metastatic melanoma ... - PubMed
Introduction: Bioimmunochemotherapy (BCT) is a combination of biological agents and cytostatics that has shown an increase in response rate (RR) in metastatic ...
Biochemotherapy in the treatment of metastatic melanoma in ...
Bioimmunochemotherapy (BCT) is a combination of biological agents and cytostatics that has shown an increase in response rate (RR) in ...
Biochemotherapy for the treatment of metastatic malignant melanoma
The results of available studies are inconsistent with regard to benefit (response, time-to-progression, and survival) and show consistently high toxicity ...
Biochemotherapy for the treatment of metastatic malignant melanoma
Current therapies for metastatic melanoma include chemotherapy and a variety of immunotherapeutic choices. With no established standard treatment option, the ...
Biochemotherapy of metastatic melanoma in patients with or without ...
Brain metastases (if present) were treated with stereotactic radiosurgery 28 days prior to systemic therapy. All patients were treated with ...
Biochemotherapy of metastatic malignant melanoma. Predictive ...
The therapeutic efficacy of biochemotherapy in metastatic malignant melanoma still carries a low remission rate, but with some durable ...
Chemotherapy Compared With Biochemotherapy for the Treatment ...
A published data meta-analysis of trials of biochemotherapy versus chemotherapy in patients with metastatic melanoma was undertaken. End points evaluated ...
Biochemotherapy of metastatic melanoma in patients with or without ...
All patients were treated with biochemotherapy consisting of either dacarbazine or temozolomide in combination with a 96-hour continuous ...
Treatment of metastatic melanoma with combined chemotherapy ...
In this study we have investigated the efficacy of combined chemotherapy using cisplatin, vinblastine, DTIC (CVD) and biological therapy using interleukin-2 ( ...
Metastatic Melanoma: Chemotherapy to Biochemotherapy
Biochemotherapy remains a promising new treatment for metastatic melanoma. A large Intergroup trial E3695 comparing concurrent biochemotherapy to ...
Chemotherapy Compared With Biochemotherapy for the Treatment ...
A published data meta-analysis of trials of biochemotherapy versus chemotherapy in patients with metastatic melanoma was undertaken. End points evaluated were ...
FDA Approves First Cellular Therapy to Treat Patients with ...
Treatment for unresectable or metastatic melanoma may include immunotherapy using PD-1 inhibitors, which are antibodies targeting certain ...
advanced or metastatic melanoma (Beyond the Basics) - UpToDate
Depending upon where and how big the metastases are, treatment may involve drug treatments, surgery, and/or radiation therapy. ... Advances in the ...
Full article: Systemic Therapy for Unresectable Metastatic Melanoma
This retrospective analysis aimed to compare the response rates and survival of patients without prior therapy with cisplatin, vinblastine, dacarbazine and ...
Treatments for metastatic melanoma skin cancer
Aldesleukin (Proleukin or interleukin-2, IL-2) is the most common immunotherapy drug used for localized therapy. It is injected directly into a tumour (called ...
Treatment of Melanoma Skin Cancer, by Stage
Metastases that can't be removed may be treated with radiation or with injections of the T-VEC vaccine (Imlygic) directly into the tumors. In ...
Treatment of metastatic malignant melanoma
Dacarbazine (DTIC) is the chemotherapy of choice with a response rate of 16%. Other chemotherapies, including cisplatinum, paclitaxel, docetaxel and the DTIC ...
Complex Combination Biochemotherapy Regimen in Advanced ...
There is currently no chemotherapy or chemoimmunotherapy regimen that has shown impact on survival in patients with metastatic melanoma. Different ...
Biochemotherapy for the treatment of metastatic malignant melanoma
Semantic Scholar extracted view of "Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review." by C. Hamm et al.